Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | CELC |
---|---|---|
09:32 ET | 1240 | 16.16 |
09:43 ET | 100 | 16.19 |
09:48 ET | 100 | 16.09 |
09:50 ET | 700 | 16.18 |
09:52 ET | 200 | 16.2175 |
09:56 ET | 100 | 16.22 |
09:57 ET | 300 | 16.26 |
09:59 ET | 300 | 16.285 |
10:03 ET | 200 | 16.275 |
10:06 ET | 814 | 16.27 |
10:08 ET | 100 | 16.255 |
10:10 ET | 948 | 16.3 |
10:12 ET | 115 | 16.32 |
10:14 ET | 508 | 16.41 |
10:19 ET | 100 | 16.37 |
10:21 ET | 500 | 16.51 |
10:26 ET | 200 | 16.54 |
10:28 ET | 100 | 16.55 |
10:32 ET | 406 | 16.41 |
10:33 ET | 100 | 16.44 |
10:39 ET | 800 | 16.35 |
10:42 ET | 309 | 16.25 |
10:44 ET | 200 | 16.255 |
10:48 ET | 300 | 16.27 |
10:53 ET | 100 | 16.255 |
10:55 ET | 200 | 16.28 |
10:57 ET | 815 | 16.215 |
11:00 ET | 300 | 16.23 |
11:02 ET | 115 | 16.19 |
11:04 ET | 217 | 16.18 |
11:06 ET | 200 | 16.22 |
11:08 ET | 215 | 16.175 |
11:09 ET | 1018 | 16.21 |
11:13 ET | 200 | 16.265 |
11:15 ET | 100 | 16.3 |
11:18 ET | 700 | 16.29 |
11:20 ET | 100 | 16.26 |
11:22 ET | 511 | 16.3 |
11:24 ET | 870 | 16.275 |
11:26 ET | 787 | 16.2404 |
11:29 ET | 100 | 16.29 |
11:31 ET | 100 | 16.27 |
11:36 ET | 825 | 16.235 |
11:38 ET | 100 | 16.23 |
11:40 ET | 418 | 16.28 |
11:42 ET | 100 | 16.24 |
11:44 ET | 562 | 16.2175 |
11:45 ET | 328 | 16.2206 |
11:47 ET | 608 | 16.24 |
11:49 ET | 100 | 16.26 |
11:51 ET | 1015 | 16.29 |
11:54 ET | 200 | 16.29 |
11:56 ET | 300 | 16.285 |
12:00 ET | 200 | 16.285 |
12:02 ET | 1650 | 16.23 |
12:05 ET | 522 | 16.25 |
12:07 ET | 300 | 16.255 |
12:09 ET | 415 | 16.248 |
12:12 ET | 400 | 16.225 |
12:14 ET | 100 | 16.22 |
12:16 ET | 111 | 16.22 |
12:20 ET | 200 | 16.22 |
12:21 ET | 216 | 16.22 |
12:23 ET | 300 | 16.24 |
12:25 ET | 100 | 16.24 |
12:27 ET | 222 | 16.24 |
12:30 ET | 400 | 16.215 |
12:32 ET | 319 | 16.23 |
12:34 ET | 300 | 16.22 |
12:36 ET | 713 | 16.26 |
12:38 ET | 1100 | 16.22 |
12:39 ET | 200 | 16.22 |
12:41 ET | 300 | 16.25 |
12:43 ET | 100 | 16.25 |
12:45 ET | 4556 | 16.27 |
12:48 ET | 300 | 16.265 |
12:50 ET | 200 | 16.265 |
12:52 ET | 1727 | 16.29 |
12:54 ET | 700 | 16.35 |
12:56 ET | 2616 | 16.33 |
12:57 ET | 4894 | 16.33 |
12:59 ET | 15252 | 16.31 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Celcuity Inc | 568.3M | -5.8x | --- |
Cassava Sciences Inc | 565.6M | -9.2x | --- |
Replimune Group Inc | 561.5M | -2.5x | --- |
Olema Pharmaceuticals Inc | 582.3M | -5.3x | --- |
Erasca Inc | 552.1M | -2.6x | --- |
Lexicon Pharmaceuticals Inc | 578.3M | -2.0x | --- |
Celcuity Inc. is a clinical-stage biotechnology company, which develops targeted therapies for the treatment of multiple solid tumor indications. Its lead therapeutic candidate is gedatolisib, a potent, small molecule reversible inhibitor, that selectively targets all Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic target of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2. Its initial clinical development programs for gedatolisib are focusing on the treatment of patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), or HR+/HER2-, advanced or metastatic breast cancer and patients with metastatic castration resistant prostate cancer. Its VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast. Its CELsignia companion diagnostic platform is able to analyze live patient tumor cells to identify new groups of cancer patients.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $568.3M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 35.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.81 |
EPS | $-2.79 |
Book Value | $5.48 |
P/E Ratio | -5.8x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.